Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nexium Capsules Specific Clinical Experience Investigation Concerning Helicobacter Pylori Eradication

NCT01435525 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01435525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01435525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nexium Capsules Specific Clinical Experience Investigation Concerning Helicobacter Pylori Eradication
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2011
Completion date
March 31, 2014
Enrollment
369 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

duodenal ulcer, early gastric cancer, gastric mucosa-associated lymphoid tissue (malt), gastric ulcer, lymphoma idiopathic thrombocytopenic purpura